Carcinoma, Hepatocellular  >>  Recombivax HB (hepatitis B vaccine recombinant)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
NCT00322361 / 2016-003981-15: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Completed
2
566
NA
Comparator: RECOMBIVAX HB™, Comparator: Modified process Hepatitis B Vaccine
Merck Sharp & Dohme LLC
Hepatitis B, Hepatocellular Carcinoma
07/07
07/07

Download Options